KAHIRA PHARMACEUTICALS & CHEMICAL INDUSTRIES COMPANY Cairo Pharmaceuticals (CPCI.CA) Reports 6 Months Results
15/02/2022
15/02/2022
Company Name : Cairo Pharmaceuticals
ISIN Code : EGS38391C016
Currency : EGP
F/S Period : from 01/07/2021 to 31/12/2021
Net Profit : 82,057,367
F/S Period: from 01/07/2020 to 31/12/2020
Net Comparative Profit : 67,004,062
Audit Status : Reviewed
Source : Cairo Pharmaceuticals
ISIN Code : EGS38391C016
Currency : EGP
F/S Period : from 01/07/2021 to 31/12/2021
Net Profit : 82,057,367
F/S Period: from 01/07/2020 to 31/12/2020
Net Comparative Profit : 67,004,062
Audit Status : Reviewed
Source : Cairo Pharmaceuticals
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Kahira Pharmaceuticals and Chemical Industries Co. published this content on 15 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 February 2022 07:56:04 UTC.
